CD4 and fibrosarcoma: AGE was shown to enhance the in vitro production of interferon-γ in splenocytes and increase the ratio of CD4+/CD8+ on implanted fibrosarcoma tumors in BALB/c mice, which improved the immune responses of mice to fibrosarcoma and inhibited tumor growth [131].